Regulation of enolase activation to promote neural protection and regeneration in spinal cord injury

Spinal cord injury (SCI) is a debilitating condition characterized by damage to the spinal cord resulting in loss of function, mobility, and sensation with no U.S. Food and Drug Administration-approved cure. Enolase, a multifunctional glycolytic enzyme upregulated after SCI, promotes pro- and anti-inflammatory events and regulates functional recovery in SCI. Enolase is normally expressed in the cytosol, but the expression is upregulated at the cell surface following cellular injury, promoting glial cell activation and signal transduction pathway activation. SCI-induced microglia activation triggers pro-inflammatory mediators at the injury site, activating other immune cells and metabolic events, i.e., Rho-associated kinase, contributing to the neuroinflammation found in SCI. Enolase surface expression also activates cathepsin X, resulting in cleavage of the C-terminal end of neuron-specific enolase (NSE) and non-neuronal enolase (NNE). Fully functional enolase is necessary as NSE/NNE C-terminal proteins activate many neurotrophic processes, i.e., the plasminogen activation system, phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B, and mitogen-activated protein kinase/extracellular signal-regulated kinase. Studies here suggest an enolase inhibitor, ENOblock, attenuates the activation of Rho-associated kinase, which may decrease glial cell activation and promote functional recovery following SCI. Also, ENOblock inhibits cathepsin X, which may help prevent the cleavage of the neurotrophic C-terminal protein allowing full plasminogen activation and phosphatidylinositol-4,5-bisphosphate 3-kinase/mitogen-activated protein kinase activity. The combined NSE/cathepsin X inhibition may serve as a potential therapeutic strategy for preventing neuroinflammation/degeneration and promoting neural cell regeneration and recovery following SCI. The role of cell membrane-expressed enolase and associated metabolic events should be investigated to determine if the same strategies can be applied to other neurodegenerative diseases. Hence, this review discusses the importance of enolase activation and inhibition as a potential therapeutic target following SCI to promote neuronal survival and regeneration.

[1]  Qi-Yong Guo,et al.  Apelin alleviated neuroinflammation and promoted endogenous neural stem cell proliferation and differentiation after spinal cord injury in rats , 2021, Journal of neuroinflammation.

[2]  F. Kimura,et al.  Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathy , 2021, Scientific Reports.

[3]  Harpreet Singh,et al.  Role of Microglia and Astrocytes in Spinal Cord Injury Induced Neuropathic Pain , 2021, Annals of neurosciences.

[4]  D. Waisman,et al.  Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy , 2021, Cancers.

[5]  F. Napolitano,et al.  The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis , 2021, Journal of clinical medicine.

[6]  N. Banik,et al.  Neuroinflammatory responses of microglia in central nervous system trauma , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  G. Caraveo,et al.  GAP-43 and BASP1 in Axon Regeneration: Implications for the Treatment of Neurodegenerative Diseases , 2020, Frontiers in Cell and Developmental Biology.

[8]  Jin Fan,et al.  Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and astrocytes , 2020, Journal of Nanobiotechnology.

[9]  Ting Li,et al.  Microglia induce the transformation of A1/A2 reactive astrocytes via the CXCR7/PI3K/Akt pathway in chronic post-surgical pain , 2020, Journal of Neuroinflammation.

[10]  N. Banik,et al.  Enolase inhibition alters metabolic hormones and inflammatory factors to promote neuroprotection in spinal cord injury , 2020, Neurochemistry International.

[11]  C. Whyte,et al.  uPA-mediated plasminogen activation is enhanced by polyphosphate , 2020, Haematologica.

[12]  Ying Xu,et al.  ERK/MAPK signalling pathway and tumorigenesis , 2020, Experimental and therapeutic medicine.

[13]  R. Kukreti,et al.  Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management , 2019, Journal of Neuroinflammation.

[14]  S. Cuzzocrea,et al.  Astrocytes: Role and Functions in Brain Pathologies , 2019, Front. Pharmacol..

[15]  L. Schaefer,et al.  When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments , 2019, Front. Cell Dev. Biol..

[16]  Y. Lei,et al.  Research progress on the PI3K/AKT signaling pathway in gynecological cancer , 2019, Molecular medicine reports.

[17]  Yuquan Wei,et al.  Targeting PI3K in cancer: mechanisms and advances in clinical trials , 2019, Molecular Cancer.

[18]  B. Lamb,et al.  Inflammation as a central mechanism in Alzheimer's disease , 2018, Alzheimer's & dementia.

[19]  J. Gensel,et al.  Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses , 2018, Neurotherapeutics.

[20]  N. Banik,et al.  New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection , 2018, Brain sciences.

[21]  S. Okada,et al.  Astrocyte reactivity and astrogliosis after spinal cord injury , 2018, Neuroscience Research.

[22]  N. Banik,et al.  Enolase and Acute Spinal Cord Injury , 2017, Journal of clinical & cellular immunology.

[23]  N. Banik,et al.  Neuron specific enolase is a potential target for regulating neuronal cell survival and death: implications in neurodegeneration and regeneration , 2017, Neuroimmunology and neuroinflammation.

[24]  J. Kos,et al.  Identification and characterization of the novel reversible and selective cathepsin X inhibitors , 2017, Scientific Reports.

[25]  April A. Cox,et al.  Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats , 2017, Neurochemical Research.

[26]  L. Tönges,et al.  Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson’s Disease and Amyotrophic Lateral Sclerosis , 2017, Front. Aging Neurosci..

[27]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[28]  Daxiong Feng,et al.  ROCK inhibition enhances neurite outgrowth in neural stem cells by upregulating YAP expression in vitro , 2016, Neural regeneration research.

[29]  April A. Cox,et al.  Neuron specific enolase: a promising therapeutic target in acute spinal cord injury , 2016, Metabolic Brain Disease.

[30]  Chuansen Zhang,et al.  The change tendency of PI3K/Akt pathway after spinal cord injury. , 2015, American journal of translational research.

[31]  J. Kos,et al.  Gamma-enolase: a well-known tumour marker, with a less-known role in cancer , 2015, Radiology and oncology.

[32]  Tania L. Slatter,et al.  Alpha-Enolase Is Upregulated on the Cell Surface and Responds to Plasminogen Activation in Mice Expressing a ∆133p53α Mimic , 2015, PloS one.

[33]  R. Leak,et al.  Microglial and macrophage polarization—new prospects for brain repair , 2015, Nature Reviews Neurology.

[34]  April A. Cox,et al.  Recent advances in the pharmacologic treatment of spinal cord injury , 2015, Metabolic Brain Disease.

[35]  D. Teupser,et al.  S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases. , 2013, Journal of neurotrauma.

[36]  Jie-zhong Yu,et al.  Rho Kinase Inhibitor Fasudil Regulates Microglia Polarization and Function , 2013, Neuroimmunomodulation.

[37]  J. Kos,et al.  Neuroprotective role of γ‐enolase in microglia in a mouse model of Alzheimer's disease is regulated by cathepsin X , 2013, Aging cell.

[38]  A. Vertegel,et al.  Spinal Cord Injury: A Review of Current Therapy, Future Treatments, and Basic Science Frontiers , 2013, Neurochemical Research.

[39]  Á. Díaz-Ramos,et al.  Requirement of Plasminogen Binding to Its Cell-Surface Receptor α-Enolase for Efficient Regeneration of Normal and Dystrophic Skeletal Muscle , 2012, PloS one.

[40]  Á. Díaz-Ramos,et al.  α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations , 2012, Journal of biomedicine & biotechnology.

[41]  Yeong-Wook Song,et al.  α-Enolase Expressed on the Surfaces of Monocytes and Macrophages Induces Robust Synovial Inflammation in Rheumatoid Arthritis , 2012, The Journal of Immunology.

[42]  J. Kos,et al.  γ-Enolase C-terminal peptide promotes cell survival and neurite outgrowth by activation of the PI3K/Akt and MAPK/ERK signalling pathways. , 2012, The Biochemical journal.

[43]  D. Butterfield,et al.  Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism , 2009, Journal of neurochemistry.

[44]  J. Kos,et al.  Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells. , 2009, The international journal of biochemistry & cell biology.

[45]  K. Preissner,et al.  Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. , 2009, Blood.

[46]  J. Kos,et al.  Carboxypeptidase cathepsin X mediates beta2-integrin-dependent adhesion of differentiated U-937 cells. , 2006, Experimental cell research.

[47]  Helmut Mack,et al.  Rho kinase, a promising drug target for neurological disorders , 2005, Nature Reviews Drug Discovery.

[48]  Jordi Félez,et al.  Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase , 2003, American journal of hematology.

[49]  A. Keller,et al.  Differential modulation of alpha, beta and gamma enolase isoforms in regenerating mouse skeletal muscle. , 2000, European journal of biochemistry.

[50]  M. Inagaki,et al.  Distribution of Rho-kinase in the bovine brain. , 1999, Biochemical and biophysical research communications.

[51]  K. Nakao,et al.  ROCK‐I and ROCK‐II, two isoforms of Rho‐associated coiled‐coil forming protein serine/threonine kinase in mice , 1996, FEBS letters.

[52]  N. Takei,et al.  Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain , 1995, Neuroscience Research.

[53]  K. Onodera,et al.  Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase. , 1994, The Journal of biological chemistry.

[54]  C H Tator,et al.  Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. , 1991, Journal of neurosurgery.

[55]  F. Suzuki,et al.  Characterization of alpha alpha, beta beta, gamma gamma and alpha gamma human enolase isozymes, and preparation of hybrid enolases (alpha gamma, beta gamma and alpha beta) from homodimeric forms. , 1983, Biochimica et biophysica acta.